Publication:
Synthesis and Anticancer Activity of New Hydrazide-hydrazoncs and Their Pd(II) Complexes

dc.contributor.authorKAYMAKÇIOĞLU, BEDİA
dc.contributor.authorTOK, FATİH
dc.contributor.authorsKocyigit-Kaymakcioglu, Bedia; Yazici, Senem Sinem; Tok, Fatih; Dikmen, Miris; Engur, Selin; Oruc-Emre, Emine Elcin; Iyidogan, Aysegul
dc.date.accessioned2022-03-12T22:38:26Z
dc.date.accessioned2026-01-11T10:56:28Z
dc.date.available2022-03-12T22:38:26Z
dc.date.issued2019
dc.description.abstractBackground: Hydrazones, one of the important classes of organic molecules, are pharmaceutical agents comprising -CO-NH-N=CH- group in the structure therefore and exhibiting significant biological activity. Methods: 5-Chloro-N'-[(substituted)methylidene] pyrazine-2-carbohydrazide (3a-g) and their Pd(II) complexes (4a-h) were synthesized and investigated in vitro anticancer activity on A549, Caco2 cancer and normal 3T3 fibroblast cell lines, using the MTT assay. Results: Anticancer activity screening results revealed that some compounds showed remarkable cytotoxic effect. Among them, 5-chloro-N'-[(4-hydroxyphenyl)methylidene] pyrazine-2-carbohydrazide (3c) displayed higher cytotoxic activity against A549 cancer cell line than the reference drug cisplatin. Conclusion: Compound 3c showed high cytotoxic activity against A549 cancer cell line but it showed low cytotoxic effect against normal 3T3 fibroblast cell line. Antiproliferative and antimetastatic effects of 3c were determined by the real-time monitoring of cell proliferative system (RTCA DP). The cell proliferation, metastatic and invasive activities of A549 cells were decreased due to increased concentration of 3c.
dc.identifier.doi10.2174/1570180815666180816124102
dc.identifier.eissn1875-628X
dc.identifier.issn1570-1808
dc.identifier.urihttps://hdl.handle.net/11424/235629
dc.identifier.wosWOS:000464613300006
dc.language.isoeng
dc.publisherBENTHAM SCIENCE PUBL LTD
dc.relation.ispartofLETTERS IN DRUG DESIGN & DISCOVERY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHydrazone
dc.subjectmetal-complexes
dc.subjectanticancer activity
dc.subjectMTT assay
dc.subjectreal-time monitoring
dc.subjectproliferative system
dc.subjectIN-VITRO
dc.subjectPROTEIN-BINDING
dc.subjectPLATINUM(II) COMPLEXES
dc.subjectCRYSTAL-STRUCTURE
dc.subjectDNA-BINDING
dc.subjectPALLADIUM(II)
dc.subjectDERIVATIVES
dc.subjectLIGANDS
dc.subjectPROLIFERATION
dc.subjectANTIOXIDANT
dc.titleSynthesis and Anticancer Activity of New Hydrazide-hydrazoncs and Their Pd(II) Complexes
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage532
oaire.citation.issue5
oaire.citation.startPage522
oaire.citation.titleLETTERS IN DRUG DESIGN & DISCOVERY
oaire.citation.volume16

Files